The latest closing stock price for PTC Therapeutics as of September 18, 2024 is 35.48.
An investor who bought $1,000 worth of PTC Therapeutics stock at the IPO in 2013 would have $1,152 today, roughly 1 times their original investment - a 7.21% compound annual growth rate over 11 years.
The all-time high PTC Therapeutics stock closing price was 77.53 on March 17, 2015.
The PTC Therapeutics 52-week high stock price is 40.69, which is 14.7% above the current share price.
The PTC Therapeutics 52-week low stock price is 17.53, which is 50.6% below the current share price.
The average PTC Therapeutics stock price for the last 52 weeks is 28.82.
An investor who bought $1,000 worth of PTC Therapeutics stock at the IPO in 2013 would have $1,152 today, roughly 1 times their original investment - a 7.21% compound annual growth rate over 11 years.
The all-time high PTC Therapeutics stock closing price was 77.53 on March 17, 2015.
The PTC Therapeutics 52-week high stock price is 40.69, which is 14.7% above the current share price.
The PTC Therapeutics 52-week low stock price is 17.53, which is 50.6% below the current share price.
The average PTC Therapeutics stock price for the last 52 weeks is 28.82.